Showing results (1-10 of 755) with videos related to
Sort By:
Pageof 76
BMC Infectious Diseases|January 3, 2025
Unusual presentation of esophageal tuberculosis: a case studyMing Xue, Yue-Can ZengContemporary Oncology (Poznan, Poland)|November 12, 2015
Radiation enhancing effects of sanazole and gemcitabine in hypoxic breast and cervical cancer cells in vitroYue-Can Zeng, Rong Wu, Yu-Ping Xiao, et al.Surgical Oncology|August 28, 2016
RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancerRui Xing, Kuan-Bing Chen, Ying Xuan, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 26, 2013
Radiation enhancing effects with the combination of sanazole and irinotecan in hypoxic HeLa human cervical cancer cell lineYue-Can Zeng, Li Yu, Yu-Ping Xiao, et al.Japanese Journal of Clinical Oncology|November 28, 2015
Pre-treatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapyYue-Can Zeng, Feng Chi, Rui Xing, et al.Critical Reviews in Oncology/Hematology|November 20, 2021
Pseudoprogression in lung cancer patients treated with immunotherapyMeng-Yu Chen, Yue-Can ZengFrontiers in Cell and Developmental Biology|July 5, 2022
Chemotherapy- and Immune-Related Gene Panel in Prognosis Prediction and Immune Microenvironment of SCLCMeng-Yu Chen, Yue-Can Zeng, Xi-He ZhaoTranslational Oncology|October 16, 2020
Combination therapy: Future directions of immunotherapy in small cell lung cancerWei Huang, Jia-Jia Chen, Rui Xing, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 8, 2012
C-reactive protein level predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapyYue-Can Zeng, Ming Xue, Feng Chi, et al.Molecular Biology Reports|December 28, 2012
Circulation insulin-like growth factor peptides and colorectal cancer risk: an updated systematic review and meta-analysisFeng Chi, Rong Wu, Yue-can Zeng, et al.Pageof 76